Shanghai Junshi Biosciences Co., Ltd.

XSSC:688180 Stock Report

Market Cap: CN¥25.0b

Shanghai Junshi Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 688180?
Owner TypeNumber of SharesOwnership Percentage
Private Companies23,991,7042.44%
Public Companies27,547,0002.8%
VC/PE Firms164,903,81316.7%
Institutions176,540,23217.9%
Individual Insiders197,344,97220%
General Public394,541,78940.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 56.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
Jun Xiong
128,916,618CN¥3.3b0%no data
11%
Loyal Valley Capital
108,357,613CN¥2.7b0%52.12%
5.74%
Hillhouse Investment Management, Ltd.
56,546,200CN¥1.4b0%0.82%
4.43%
Shenzhen Origin Venture Capital Co., Ltd.
43,584,000CN¥1.1b0%no data
3.31%
China Asset Management Co. Ltd.
32,550,617CN¥825.7m0%0.14%
2.8%
Greenland Holdings Corporation Limited
27,547,000CN¥698.8m0%no data
2.2%
Yuqing Zhou
21,680,800CN¥550.0m0%no data
1.67%
E Fund Management Co., Ltd.
16,466,434CN¥417.7m0%0.07%
1.36%
Shanghai Jiacai Investment Management Co., Ltd.
13,410,200CN¥340.2m0%no data
1.34%
Hui Feng
13,180,000CN¥334.3m0%no data
1.06%
Greenland Financial Investment Holding Group Co., Ltd., Asset Management Arm
10,429,200CN¥264.5m0%37.3%
0.88%
The Vanguard Group, Inc.
8,693,139CN¥220.5m0.34%no data
0.88%
Zhuobing Zhang
8,648,000CN¥219.4m0%no data
0.84%
China Merchants Fund Management Company Ltd.
8,262,056CN¥209.6m0%0.14%
0.81%
GF Fund Management Co., Ltd.
7,998,000CN¥202.9m0%0.06%
0.79%
Yi Tang
7,774,500CN¥197.2m6.76%no data
0.6%
Yali Du
5,882,000CN¥149.2m0%no data
0.49%
ICBC Credit Suisse Asset Management Co., Ltd.
4,807,005CN¥121.9m0%0.09%
0.47%
Yinhua Fund Management Co., Ltd.
4,664,571CN¥118.3m0%0.11%
0.47%
Suzhou Benyu Tianyuan Biological Technology Partnership
4,600,000CN¥116.7m0%no data
0.44%
Shanghai Baoying Asset Management Co., Ltd.
4,372,144CN¥110.9m0%100.0%
0.44%
China Universal Asset Management Company Ltd.
4,346,220CN¥110.2m0%0.06%
0.44%
China Southern Asset Management Co., Ltd.
4,343,416CN¥110.2m0%0.04%
0.44%
Xiaojun Meng
4,288,400CN¥108.8m0%no data
0.38%
Shufang Gao
3,789,720CN¥96.1m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Junshi Biosciences Co., Ltd. is covered by 19 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Congmin YuanCitic Securities Co., Ltd.
Tan Huan GanCitic Securities Co., Ltd.
Muk Tsz YungCitigroup Inc